Researcher
Lindsey Devisscher
- Keywords:Pharmacology, gastroenterology, hepatology, Macrophages, Immunology, Immuno-oncology
- Disciplines:Gastro-enterology and hepatology not elsewhere classified, Pharmacology not elsewhere classified, Gastro-enterology, Hepatology, Inflammation, Innate immunity, Cancer therapy
Affiliations
- Department of Basic and Applied Medical Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Pharmacology (Department)
Member
From1 Aug 2018 → 30 Sep 2018 - Department of Internal medicine (Department)
Member
From1 Oct 2010 → 30 Sep 2018 - Department of Large Animal Surgery, Anaesthesia and Orthopaedics (Department)
Member
From1 Oct 2006 → 31 Jul 2008
Projects
1 - 10 of 17
- Facility : Patiënt-afgeleide xenograft modellen – UGent;From1 Feb 2024 → TodayFunding: BOF - research organisations
- Maternal insulin resistance: fueling offspring fatty liver via metabolic dysregulation?From1 Oct 2023 → TodayFunding: FWO senior postdoctoral fellowship
- Osteopontin and bile duct-associated macrophages in primary sclerosing cholangitisFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Tissue and cell culture core facilityFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Cofunding core facility - Animalarium,Radiological and Radiobiological Techniques, Histology CoreFrom1 Nov 2022 → TodayFunding: BOF - research organisations
- PSMA beyond the prostate: exploring prostate-specific membrane antigen as a target in the treatment of late-stage malignancies of the thyroid, liver and the head and neckFrom1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imagingFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomicsFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- NADPH OXIDASE 1 INHIBITION AS NEW THERAPEUTIC OPTION FOR HEPATOCELLULAR CARCINOMAFrom1 Jan 2022 → TodayFunding: Nonprofit institution or equivalents
Publications
1 - 10 of 17
- Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis(2024)
Authors: Kevin De Muynck, Lander Heyerick, Federico Francesco De Ponti, Bart Vanderborght, Tim Meese, Sanne Van Campenhout, Leen Baudonck, Eva Gijbels, Pedro M. Rodrigues, Jesus M. Banales, et al.
Pages: 269 - 288 - Dynamics of training and acute exercise-induced shifts in muscular glucose transporter (GLUT) 4, 8, and 12 expression in locomotion versus posture muscles in healthy horses(2023)
Authors: Carmen Vidal Moreno de Vega, Diete Lemmens, Constance de Meeus d'Argenteuil, Berit Boshuizen, Lorie De Maré, Luc Leybaert, Klara Goethals, Jean Eduardo de Oliveira, Guilherme Hosotani, Dieter Deforce, et al.
- Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma(2023)
Authors: Bart Vanderborght, Kevin De Muynck, Eva Gijbels, Sander Lefere, Charlotte Scott, Martin Guilliams, Alain Beschin, Mathieu Vinken, Xavier Verhelst, Anja Geerts, et al.
Pages: 2615 - 2628 - Gelatin-based hybrid hydrogel scaffolds : toward physicochemical liver mimicry(2023)
Authors: Nathan Carpentier, Louis Van der Meeren, Andre Skirtach, Lindsey Devisscher, Hans Van Vlierberghe, Peter Dubruel, Sandra Van Vlierberghe
Pages: 4333 - 4347 - Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice(2022)
Authors: M Kabbani, E Michailidis, S Steensels, CG Fulmer, JM Luna, J Le Pen, M Tardelli, B Razooky, I Ricardo-Lax, C Zou, et al.
- The gut–liver axis in chronic liver disease : a macrophage perspective(2021)
Authors: Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher
- Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient(2021)
Authors: Eva Gijbels, Lindsey Devisscher, Mathieu Vinken
- Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model(2020)
Authors: Sanne Van Campenhout, Laurentijn Tilleman, Sander Lefere, Aster Vandierendonck, Sarah Raevens, Xavier Verhelst, Anja Geerts, Filip Van Nieuwerburgh, Hans Van Vlierberghe, Lindsey Devisscher
- Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver(2020)
Authors: Anneleen Remmerie, Liesbet Martens, Tinne Thoné, Angela Castoldi, Ruth Seurinck, Benjamin Pavie, Joris Roels, Bavo Vanneste, Sofie De Prijck, Mathias Vanhockerhout, et al.
Pages: 641 - 657.e1–e14 - The angiopoietin/tie2 pathway in hepatocellular carcinoma(2020)
Authors: Bart Vanderborght, Sander Lefere, Hans Van Vlierberghe, Lindsey Devisscher